Electroceuticals in the Gastrointestinal Tract
- PMID: 33127099
- PMCID: PMC8186669
- DOI: 10.1016/j.tips.2020.09.014
Electroceuticals in the Gastrointestinal Tract
Abstract
The field of electroceuticals has attracted considerable attention over the past few decades as a novel therapeutic modality. The gastrointestinal (GI) tract (GIT) holds significant potential as a target for electroceuticals as the intersection of neural, endocrine, and immune systems. We review recent developments in electrical stimulation of various portions of the GIT (including esophagus, stomach, and small and large intestine) and nerves projecting to the GIT and supportive organs. This has been tested with varying degrees of success for several dysmotility, inflammatory, hormonal, and neurologic disorders. We outline a vision for the future of GI electroceuticals, building on advances in mechanistic understanding of GI physiology coupled with novel ingestible technologies. The next wave of electroceutical therapies will be minimally invasive and more targeted than current approaches, making them an indispensable tool in the clinical armamentarium.
Keywords: electrical stimulation; electroceuticals; gastrointestinal tract.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Figures
References
-
- Aristotle, History of Animals. 1993: Harvard University Press.
-
- Jungheim M, et al. , Impact of neuromuscular electrical stimulation on upper esophageal sphincter dynamics: a high-resolution manometry study. Ann Otol Rhinol Laryngol, 2015. 124(1): p. 5–12. - PubMed
-
- Zhang L, et al. , Study on effects of electrical stimulation on rabbit esophageal body motility in vivo. Physiol Res, 2018. 67(2): p. 275–282. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
